🧠 Nootropic Stack Interaction Safety Simulator

One Compound, Limited but Existing Safety Data

A single nootropic has some individual safety data, thin but real.

• 1: Supplements stacked (baseline compound only)
• 0%: Unknown-interaction risk (no pairing to assess)
• 0: Overlapping mechanisms (nothing to overlap with)
• 100%: Safety-data coverage (single-agent studies apply)

What single-agent safety data covers

Individual dose studies exist. Combination effects are simply untested territory.

Why this baseline is deceptively reassuring

Solo safety does not predict behavior once other compounds enter the mix.

The Stack Begins — Combination Data Goes Missing

Adding compound two creates a pairing nobody has formally studied.

• 2: Supplements stacked (first pairing formed)
• ~15%: Unknown-interaction risk (one untested pair)
• 0–1: Overlapping mechanisms (depends on compounds chosen)
• ~80%: Safety-data coverage (pairing data essentially absent)

Why pair data rarely exists

Regulators and trials rarely test consumer-driven supplement combinations.

The first untested interaction line

One connecting line appears — one relationship with zero formal safety review.

Three-Plus Supplements — Risk Multiplies, Not Adds

Each new supplement adds many new pairs, not just one more risk.

• 3–6: Supplements stacked (growing user-built stack)
• 40–90%: Unknown-interaction risk (combinatorial pair growth)
• 1–3: Overlapping mechanisms (stimulant, CV, enzyme overlap)
• 20–50%: Safety-data coverage (shrinking fast with each add)

Combinatorial pair growth explained

Pairs grow as n(n-1)/2 — six supplements make fifteen untested pairs.

Why users rarely notice the growth

Each addition feels small, but the interaction count grows much faster.

Where the Unknowns Actually Come From

Overlapping stimulant, cardiovascular, and metabolic pathways drive real risk.

• Compounding: Stimulant-like overlap (additive CNS excitation)
• Additive: Cardiovascular strain (heart rate, blood pressure load)
• Unpredictable: Metabolic/enzyme overlap (shared liver enzyme pathways)
• 0–3: Overlapping mechanisms (toggle sets active overlap count)

Stimulant-like mechanism stacking

Multiple stimulant-like compounds can push excitatory effects past comfortable limits.

Cardiovascular and enzyme overlap

Shared metabolic enzyme pathways create unpredictable blood-level swings.

The Unknown Safety Zone Keeps Growing

More compounds stacked means a larger zone nobody has ever tested.

• 6: Max stack modeled (supplements in this simulator)
• 15: Max untested pairs (at six-supplement stack size)
• as low as 5%: Safety-data coverage (at max stack + overlaps)
• never: Tested combination (this exact stack, untested)

The core takeaway

No study has ever evaluated this exact personal combination of supplements.

A practical caution

Fewer compounds and known mechanisms keep the unknown zone smaller.